載入...
Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
The present Perspective examined the latest evidence on the association between the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and the incidence/mortality of coronavirus disease 2019 (COVID‐19). Our critical appraisal from existing literature does...
Na minha lista:
| 發表在: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7524232/ https://ncbi.nlm.nih.gov/pubmed/33121220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12952 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|